[go: up one dir, main page]

Autilio-Gambetti et al., 1988 - Google Patents

The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types

Autilio-Gambetti et al., 1988

View PDF @Full View
Document ID
9183943694637599601
Author
Autilio-Gambetti L
Morandi A
Tabaton M
Schaetzle B
Kovacs D
Perry G
Greenberg B
Gambetti P
Publication year
Publication venue
FEBS letters

External Links

Snippet

The vascular and parenchymal amyloid deposits in Alzheimer disease (AD), normal aging and Down syndrome are mainly composed of a 4 kDa polypeptide (A4), which derives from a larger precursor protein (APP). There is evidence that APP is a transmembrane …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Klier et al. Amyloid β-protein precursor is associated with extracellular matrix
Autilio-Gambetti et al. The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types
US5538845A (en) Beta-amyloid peptide production inhibitors and methods for their identification
Cataldo et al. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin
Bush et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets.
Bancher et al. Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein
Moya et al. The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis
Dickson et al. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques
Porchet et al. Analysis of gial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease
Moir et al. Relative increase in Alzheimer's disease of soluble forms of cerebral Aβ amyloid protein precursor containing the Kunitz protease inhibitory domain
Schmidt et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease
Snow et al. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease.
Perlmutter et al. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease
Okamoto et al. Reexamination of granulovacuolar degeneration
Löffler et al. β‐amyloid precursor protein isoforms in various rat brain regions and during brain development
Lahiri et al. Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines
Endoh et al. Lack of the car☐ yl terminal sequence of tau in ghost tangles of Alzheimer's disease
Dickson et al. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site
Wisniewski et al. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells
Ko et al. An immunochemical study on tau glycation in paired helical filaments
Stern et al. Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system
Prior et al. Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid
Ghiso et al. Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization
US5849600A (en) Diagnostic assays for Alzheimer's disease
Moir et al. Human brain βA4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization